Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Metagenics Signs Commercialization Deals - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Metagenics Signs Commercialization Deals

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Metagenics Signs Commercialization Deals
ReGen Therapeutics Plc. (ReGen), London, U.K., has entered into an exclusive license agreement with Metagenics, Inc., San Clemente, CA, for the commercialization of ReGen’s Colostrinin as a human nutraceutical in North America. The agreement is conditional on, amongst other things, satisfactory completion of toxicology testing on Colostrinin and of due diligence by Metagenics on the Colostrinin manufacturing facilities. Subject to satisfactory completion of the conditions of the agreement and requisite U.S. regulatory filings, ReGen currently anticipates launch of a human nutraceutical containing Colostrinin during the first half of 2007.
In other news, Metagenics has teamed up with Carotech Inc., Edison, NJ, for the commercialization of Tocomin SupraBio, a patented, bio-enhanced, natural, full-spectrum palm tocotrienol complex for the healthcare practitioner channel. Caro­tech will collaborate with Metagenics to formulate new and unique products with Tocomin SupraBio, as well as establish the best commercialization strategy for introducing this novel tocotrienol complex to the healthcare practitioner channel in North America.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters